Tearsheet

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 23%
Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 27x, P/EPrice/Earnings or Price/(Net Income) is 59x
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 30%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 27%
Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.5%
2 Low stock price volatility
Vol 12M is 36%
 
3 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine, and Cloud Computing. Themes include Health Data Analytics, AI in Healthcare Management, Show more.
 
0 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 23%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 30%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 27%
2 Low stock price volatility
Vol 12M is 36%
3 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine, and Cloud Computing. Themes include Health Data Analytics, AI in Healthcare Management, Show more.
4 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 27x, P/EPrice/Earnings or Price/(Net Income) is 59x
5 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.5%

Valuation, Metrics & Events

WAY Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

1. Significant Insider Selling Exceeding USD 5 Million: A key factor in the stock's negative movement was substantial insider selling. On September 12, 2025, Director Paul G. Moskowitz sold 4,295,139 shares of Waystar stock, totaling approximately $168.4 million. Additionally, over the three months leading up to December 3, 2025, corporate insiders collectively sold approximately 4.5 million shares worth around $176.4 million.

2. Measured Market Reaction and Profit-Taking Despite Strong Q3 Earnings: Despite Waystar reporting strong third-quarter 2025 results on October 29, 2025, which exceeded analyst expectations for both revenue and earnings and included raised full-year guidance, the market's initial reaction was described as "measured." The stock experienced a slight decline in after-hours trading, suggesting that investors might have been taking profits following prior appreciation rather than significantly buying into the positive news.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
WAY Return------4%-4%
Peers Return19%16%-4%-24%2%-26%-23%
S&P 500 Return16%27%-19%24%23%17%112%

Monthly Win Rates [3]
WAY Win Rate----100%60% 
Peers Win Rate20%23%23%27%27%49% 
S&P 500 Win Rate58%75%42%67%75%70% 

Max Drawdowns [4]
WAY Max Drawdown------8% 
Peers Max Drawdown-16%-2%-32%-33%-23%-36% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: OMCL, MDRX, BEAT, CARL, HTFL.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/4/2025 (YTD)

How Low Can It Go

WAY has limited trading history. Below is the Health Care sector ETF (XLV) in its place.

Unique KeyEventXLVS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-16.1%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven19.1%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven599 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-28.8%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven40.4%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven116 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-15.8%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven18.8%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven326 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-40.6%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven68.3%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1100 days1480 days

Compare to


In The Past

SPDR Select Sector Fund's stock fell -16.1% during the 2022 Inflation Shock from a high on 4/8/2022. A -16.1% loss requires a 19.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Waystar (WAY)

Better Bets than Waystar (WAY)

Trade Ideas

Select past ideas related to WAY. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
10.0%10.0%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.7%-7.7%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.9%6.9%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
11.5%11.5%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
8.9%8.9%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
10.0%10.0%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.7%-7.7%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.9%6.9%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
11.5%11.5%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
8.9%8.9%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Waystar

Peers to compare with:

Financials

WAYOMCLMDRXBEATCARLHTFLMedian
NameWaystar Omnicell Veradigm HeartBeamCarlsmed HeartFlow 
Mkt Price35.4039.615.000.7214.4128.9321.67
Mkt Cap6.21.80.50.0--1.2
Rev LTM1,0401,178588033139363
Op Inc LTM24317-20-21-24-61-20
FCF LTM2859483-15-30-9034
FCF 3Y Avg-126-79-13---13
CFO LTM308153116-15-29-8550
CFO 3Y Avg-183-22-13---13

Growth & Margins

WAYOMCLMDRXBEATCARLHTFLMedian
NameWaystar Omnicell Veradigm HeartBeamCarlsmed HeartFlow 
Rev Chg LTM14.8%10.7%1.8%---10.7%
Rev Chg 3Y Avg--3.0%-20.1%----11.5%
Rev Chg Q11.9%10.0%-9.7%---10.0%
QoQ Delta Rev Chg LTM2.8%2.5%-2.5%---2.5%
Op Mgn LTM23.4%1.5%-3.3%--71.4%-44.4%-3.3%
Op Mgn 3Y Avg--2.0%4.4%---1.2%
QoQ Delta Op Mgn LTM2.6%0.1%-13.3%---0.1%
CFO/Rev LTM29.6%13.0%19.7%--86.4%-61.5%13.0%
CFO/Rev 3Y Avg-16.0%-4.1%---5.9%
FCF/Rev LTM27.4%8.0%14.2%--88.9%-65.0%8.0%
FCF/Rev 3Y Avg-11.0%-14.2%----1.6%

Valuation

WAYOMCLMDRXBEATCARLHTFLMedian
NameWaystar Omnicell Veradigm HeartBeamCarlsmed HeartFlow 
Mkt Cap6.21.80.50.0--1.2
P/S6.41.20.9---1.2
P/EBIT27.280.9-8.8-2.1--12.6
P/E59.569.6-5.9-2.1--28.7
P/CFO21.59.04.4-2.7--6.7
Total Yield1.7%1.4%-17.0%-48.1%---7.8%
Dividend Yield0.0%0.0%0.0%0.0%--0.0%
FCF Yield 3Y Avg-6.9%-1.5%-27.2%---1.5%
D/E0.20.10.40.0--0.2
Net D/E0.10.0-0.4-0.1---0.1

Returns

WAYOMCLMDRXBEATCARLHTFLMedian
NameWaystar Omnicell Veradigm HeartBeamCarlsmed HeartFlow 
1M Rtn-5.6%14.8%4.2%-56.4%16.6%-14.6%-0.7%
3M Rtn-4.9%19.6%1.0%-48.6%11.6%-15.1%-2.0%
6M Rtn-11.7%28.3%11.1%-56.1%---0.3%
12M Rtn18.5%-13.7%-53.7%-77.1%---33.7%
3Y Rtn--19.9%-73.3%-85.1%---73.3%
1M Excs Rtn-6.8%13.5%2.9%-57.6%15.3%-15.9%-2.0%
3M Excs Rtn-10.8%17.6%-2.9%-52.5%7.3%-12.7%-6.9%
6M Excs Rtn-27.2%12.9%-4.3%-71.6%---15.7%
12M Excs Rtn1.2%-30.2%-63.6%-88.9%---46.9%
3Y Excs Rtn--90.8%-146.1%-156.9%---146.1%

Financials

Price Behavior

Short Interest

Short Interest: As Of Date11142025
Short Interest: Shares Quantity8,405,241
Short Interest: % Change Since 10312025-6.0%
Average Daily Volume1,845,657
Days-to-Cover Short Interest4.55
Basic Shares Quantity174,352,079
Short % of Basic Shares4.8%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251029202510-Q 9/30/2025
6302025730202510-Q 6/30/2025
3312025430202510-Q 3/31/2025
12312024218202510-K 12/31/2024
93020241106202410-Q 9/30/2024
6302024807202410-Q 6/30/2024
123120236072024424B4 12/31/2023
1231202210162023S-1 12/31/2022